124 related articles for article (PubMed ID: 18355449)
1. Calcium-regulated intramembrane proteolysis of the RAGE receptor.
Galichet A; Weibel M; Heizmann CW
Biochem Biophys Res Commun; 2008 May; 370(1):1-5. PubMed ID: 18355449
[TBL] [Abstract][Full Text] [Related]
2. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
[TBL] [Abstract][Full Text] [Related]
3. EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes.
Huang SM; Chang YH; Chao YC; Lin JA; Wu CH; Lai CY; Chan KC; Tseng ST; Yen GC
Mol Nutr Food Res; 2013 Dec; 57(12):2264-8. PubMed ID: 23901023
[TBL] [Abstract][Full Text] [Related]
4. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
Raucci A; Cugusi S; Antonelli A; Barabino SM; Monti L; Bierhaus A; Reiss K; Saftig P; Bianchi ME
FASEB J; 2008 Oct; 22(10):3716-27. PubMed ID: 18603587
[TBL] [Abstract][Full Text] [Related]
5. RAGE processing in chronic airway conditions: involvement of Staphylococcus aureus and ECP.
Van Crombruggen K; Holtappels G; De Ruyck N; Derycke L; Tomassen P; Bachert C
J Allergy Clin Immunol; 2012 Jun; 129(6):1515-21.e8. PubMed ID: 22460069
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
7. The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP).
Houri N; Huang KC; Nalbantoglu J
PLoS One; 2013; 8(8):e73296. PubMed ID: 24015300
[TBL] [Abstract][Full Text] [Related]
8. Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.
Zhang L; Postina R; Wang Y
Cell Mol Life Sci; 2009 Dec; 66(24):3923-35. PubMed ID: 19672558
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function.
Braley A; Kwak T; Jules J; Harja E; Landgraf R; Hudson BI
J Biol Chem; 2016 Jun; 291(23):12057-73. PubMed ID: 27022018
[TBL] [Abstract][Full Text] [Related]
10. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Ohlmeier S; Mazur W; Salmenkivi K; Myllärniemi M; Bergmann U; Kinnula VL
Proteomics Clin Appl; 2010 Jan; 4(1):97-105. PubMed ID: 21137019
[TBL] [Abstract][Full Text] [Related]
11. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
[TBL] [Abstract][Full Text] [Related]
12. Induction of RAGE shedding by activation of G protein-coupled receptors.
Metz VV; Kojro E; Rat D; Postina R
PLoS One; 2012; 7(7):e41823. PubMed ID: 22860017
[TBL] [Abstract][Full Text] [Related]
13. ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.
Tousseyn T; Thathiah A; Jorissen E; Raemaekers T; Konietzko U; Reiss K; Maes E; Snellinx A; Serneels L; Nyabi O; Annaert W; Saftig P; Hartmann D; De Strooper B
J Biol Chem; 2009 Apr; 284(17):11738-47. PubMed ID: 19213735
[TBL] [Abstract][Full Text] [Related]
14. ADAM10 modulates calcitriol-regulated RAGE in cardiomyocytes.
Lee TW; Kao YH; Lee TI; Chen YJ
Eur J Clin Invest; 2017 Sep; 47(9):675-683. PubMed ID: 28722189
[TBL] [Abstract][Full Text] [Related]
15. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
16. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.
Hsieh HL; Schäfer BW; Weigle B; Heizmann CW
Biochem Biophys Res Commun; 2004 Apr; 316(3):949-59. PubMed ID: 15033494
[TBL] [Abstract][Full Text] [Related]
17. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.
Lee EJ; Park EY; Mun H; Chang E; Ko JY; Kim DY; Park JH
FASEB J; 2015 Aug; 29(8):3506-14. PubMed ID: 25934702
[TBL] [Abstract][Full Text] [Related]
18. Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.
Kojro E; Postina R
J Alzheimers Dis; 2009; 16(4):865-78. PubMed ID: 19387119
[TBL] [Abstract][Full Text] [Related]
19. Release of a membrane-bound death domain by gamma-secretase processing of the p75NTR homolog NRADD.
Gowrishankar K; Zeidler MG; Vincenz C
J Cell Sci; 2004 Aug; 117(Pt 18):4099-111. PubMed ID: 15280425
[TBL] [Abstract][Full Text] [Related]
20. A single high-fat meal alters human soluble RAGE profiles and PBMC RAGE expression with no effect of prior aerobic exercise.
Fuller KNZ; Valentine RJ; Miranda ER; Kumar P; Prabhakar BS; Haus JM
Physiol Rep; 2018 Jul; 6(14):e13811. PubMed ID: 30047241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
